We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Repurposed Drug Could Open Door to More Stem Cell Transplants

News   Dec 21, 2017 | Original story from University of British Columbia

 
Repurposed Drug Could Open Door to More Stem Cell Transplants

This is Peter Zandstra, director of UBC's School of Biomedical Engineering and Michael Smith Laboratories, and chief scientific officer of the Centre for Commercialization of Regenerative Medicine. Credit: UBC/Paul Joseph

 
 
 

RELATED ARTICLES

Probing Yeast Cells to Understand Cell Misregulation

News

Manipulating yeast with optogenetics and microfluidics to explore the MAP kinase pathway may be key for drug discovery.

READ MORE

Genetic Similarities Found Across Multiple Cancer Types

News

Study could lead to new treatments for advanced epithelial cancers such as lung and prostate cancers.

READ MORE

Therapeutic RNAs get Helping Hand from Green Tea Compound

News

An antioxidant in green tea called epigallocatechin gallate has been found to have a surprising use: sneaking therapeutic RNAs into cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE